FDA Inspection 1046160 — Lance Ellis
The FDA completed an inspection of Lance Ellis on Feb 27, 2018 in Conroe, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Conroe, TX (United States)